Ligand validation:6NH1

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NH1_BTB_A_504	65%	56%	0.117	0.917	0.53	1.13	-	-	0	0	100%	1
6NH1_BTB_B_505	54%	67%	0.15	0.914	0.53	0.72	-	-	1	0	100%	1
6NH1_BTB_A_510	49%	10%	0.193	0.942	1.64	2.65	2	2	14	0	100%	1
6NH1_BTB_B_511	45%	39%	0.182	0.913	0.82	1.54	1	2	2	0	100%	1
6NH1_BTB_D_504	43%	45%	0.181	0.904	0.73	1.36	-	1	4	0	100%	1
6NH1_BTB_A_503	41%	77%	0.191	0.905	0.35	0.55	-	-	2	0	100%	1
6NH1_BTB_D_505	31%	56%	0.25	0.92	0.63	1.06	-	-	5	0	100%	1
6NH1_BTB_A_505	26%	72%	0.17	0.81	0.43	0.66	-	-	2	0	100%	1
6NH1_BTB_B_506	22%	69%	0.271	0.889	0.38	0.79	-	-	5	0	100%	1
6NH1_BTB_B_510	20%	69%	0.235	0.839	0.38	0.82	-	-	3	0	100%	1
6NH1_BTB_C_504	18%	83%	0.177	0.764	0.48	0.31	-	-	9	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.